Sunday, 25 Oct 2026

Empowering Chinese Pharma’s Global Expansion

Contact US
Insight,  China's Pharmaceutical Industry
  • Home
  • About US
  • Policy Hub
  • Categories
    • Drug
    • Company
    • Deals
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Legal / IP
    • Digital
  • Privacy Policy
  • Contact US
My News
  • Cancer
  • Clinical trial approval / initiation
  • Product approvals
  • Clinical trial results
  • Finance
  • ADC / XDC
  • Finanical Reports
  • Biotech
  • Market approval filings
  • PD-1/L1
Insight,  China's Pharmaceutical IndustryInsight,  China's Pharmaceutical Industry
  • Read History
Search
  • Pages
    • Home
    • Blog Index
    • POLICY HUB
    • Contact Us
  • Personalized
    • Read History
  • Categories
    • Company
    • Drug
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Digital
    • Legal / IP
    • Deals
Have an existing account? Sign In
Follow US
CompanyDeals

Healsun Biopharm Raises USD 36.7 Million in Series B Financing for Antibody CDMO Expansion

February 13, 2025
CompanyDrug

Sirnaomics Initiates Phase I/II Trial for STP705 in Facial Squamous Cell Carcinoma

February 13, 2025
Policy / Regulatory

NHC, NDRC Issue Guidelines to Boost China’s Birth Rates with Reproductive Support Measures

February 13, 2025
CompanyDeals

Biocytogen Pharmaceuticals Makes HKSE Debut with USD 70 Million IPO

February 13, 2025
CompanyDrug

CSPC Pharmaceutical’s Mitoxantrone Liposome Approved for NMOSD Clinical Study

February 13, 2025
CompanyDeals

Jemincare Licenses Oral Androgen Receptor Degrader to Roche’s Genentech

February 14, 2025
CompanyDrug

Spinraza’s NRDL Inclusion Boosts SMA Patient Treatment in China

February 14, 2025
Policy / Regulatory

CDE Releases Draft Guidelines for RWE-Backed Drug Registration Applications

February 14, 2025
Drug

ICT’s GCC19CART Enters US Phase I Study for Colorectal Cancer

February 14, 2025
Drug

BRL Medicine’s BRL-101 Receives Clinical Trial Approval for Beta-Thalassemia

February 14, 2025
CompanyLegal / IP

GenScript Biotech Sues Former CSO Fan Xiaohu for Trade Secret Infringement

February 14, 2025
CompanyDrug

Innovent Biologics Initiates Phase I Study of IBI311 for Thyroid-Associated Ophthalmopathy

February 14, 2025
1 2 … 7 8 9 10 11 … 21 22
Insight,  China's Pharmaceutical Industry

Information You Can Trust: Stay instantly connected with breaking stories and live updates. From politics and technology to entertainment and beyond, we provide real-time coverage you can rely on, making us your dependable source for 24/7 news.

Youtube Medium Rss

About Company

  • Contact Us
  • Advertise with US
  • Complaint
  • Our Team
  • Our Values
  • Privacy Policy
Subscribe Now for Real-time Updates on the Latest Stories!

© 2026 Fineline Information & Technology. Independent intelligence on China’s pharmaceutical industry.  All Rights Reserved.

Fineline Information & Technology
Welcome to Fineline Cube!
Username or Email Address
Password

Lost your password?

Not a member? Sign Up